Global Markets for Telemedicine Technologies – Yahoo Finance
Report Scope: The scope of this report is broad and covers the components available in the telemedicine market and potential end-user applications. Revenue forecasts from 2022 to 2027 are given for components, applications and end-users with estimated value derived from the revenues of manufacturers.
New York, Aug. 23, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Markets for Telemedicine Technologies” – https://www.reportlinker.com/p0801566/?utm_source=GNW
The report also includes a discussion on the major players in each regional telemedicine market.Further, it explains major drivers and regional dynamics of the global telemedicine market.
The report concludes with a look at the vendor landscape and includes detailed profiles of major vendors in the global telemedicine market.
Report Includes:
– 47 data tables and 44 additional tables
– An up-to-date review and analysis of the global markets for telemedicine technologies
– Analyses of the global market trends, with historic market revenue (sales data) from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
– Highlights of the current and future market potential for telemedicine technologies, and areas to forecast this market into various segments and sub-segments
– Estimation of the actual market size (value based) for global telemedicine market in USD million terms, market forecast, and corresponding market share analysis by business segment (component), application, end user, and geographic region
– Market assessment of the telemedicine products and technologies currently available, new developments, spending trends, and revenue prospects for this innovation driven market
– Discussion of the telemedicine industry value chain analysis providing a systematic study of the key intermediaries involved, which could further assist stakeholders in formulating appropriate strategies
– Updated information on key developments, mergers and acquisitions (M&A) activities, collaborations, joint ventures and partnerships in the telemedicine industry.
– Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
– Descriptive company profiles of the leading global players, including Allscripts Healthcare Solutions Inc., Boston Scientific Corp., Cerner Corp., Cisco Systems Inc., GE Healthcare, Medtronic, Philips Healthcare and Siemens Healthcare
Summary:
Telemedicine is the delivery of medical services to any location with the help of advanced telecommunications technology. Telemedicine technology incorporates digital communication and telecommunications technologies to treat patients residing in any location that can be reached by these technologies.
The COVID-19 pandemic has resulted into a global lockdown, which has increased the demand for telehealth services, along with a growing focus on low-cost healthcare services.This has resulted in a growing market for telemedicine.
According to the Institute for Health Metrics and Evaluation, global expenditures on healthcare are expected to rise from $REDACTED in 2017 to $REDACTED by 2040.Annual global public spending on health rose by an average REDACTED% from 2000 to 2017.
However, it is worth noting that the annual rise has dropped from REDACTED% from 2000 to 2010 to REDACTED% from 2010 to 2017.
Telemedicine has transformed the role of physicians and increased access to health services for patients worldwide. This has led to a greater number of technology startups and increased investments in the telemedicine market.
For instance, in May 2020, American Well raised $REDACTED, to keep up with the escalating demand of telemedicine. In August 2018, MDLive Inc. received financing of $REDACTED from telehealth investor Health Velocity Capital; from partners Health Care Service Corp. (HCSC) and Cigna Corp.; and from contributions from Industry Ventures and Novo Holdings A/S.
In the meantime, the use of connected devices such as smartphones and tablets for real-time patient monitoring and diagnosis is growing rapidly.This trend has led to the improvement in healthcare services and increased patient-care efficiency and data collection.
The U.S. spends about REDACTED% of its GDP on healthcare, which could reach by more than $REDACTED with the help of connected devices in diagnostic treatment, chronic disease management and preventive care of the patients.
The global telemedicine market is projected to grow at a CAGR of REDACTED% during the forecast period of 2022 through 2027. In 2027, total revenues are expected to reach $REDACTED, up from $REDACTED in 2020.
This report provides an analysis of each market segment, including components, applications and end users.The businesst segment consists of hardware, software and services.
The hardware segment accounted for REDACTED% of the overall telemedicine market in 2021 in terms of revenue.By the end of 2027, total revenue from hardware in the telemedicine market is expected to reach $REDACTED.
The software segment is expected to have a CAGR of REDACTED% through the forecast period.
Read the full report: https://www.reportlinker.com/p0801566/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett buys or sells stock, everyday investors and Wall Street professionals all pay close attention. The best news for investors is that following Buffett's trading activity, and riding his coattails, if you choose to do so, is pretty easy. A 13F provides an under-the-hood look at what money managers with at least $100 million in assets under management were buying, selling, and holding in the most-recent quarter.
In the article, we will discuss 10 stocks to sell according to Ray Dalio. To skip the detailed analysis of Ray Dalio’s Bridgewater Associates, go directly to 5 Stocks to Sell Now According to Ray Dalio. Raymond Thomas Dalio is an American billionaire investor, hedge fund manager, and philanthropist. He is also the author of […]
Stocks under $5 a share (aka penny stocks) are rarely worth considering as an investment vehicle. Companies that occupy this portion of the equity price spectrum tend to have major fundamental flaws, poor management teams, and/or unfavorable competitive positions within their industry. Speaking to this point, several of the best-performing equities over the prior 12 months were former penny stocks.
A down market is the perfect opportunity to buy into these highly profitable and attractively priced stocks.
Yahoo Finance Live anchors discuss Peloton stock performance on news that it will partner with Amazon to bring fitness equipment and accessories to consumers.
Yahoo Finance's Brian Sozzi breaks down how Intel's deal with Brookfield means for the company's dividend and balance sheet.
The growth investor that became a rock star after a market-thumping run in 2020 as the co-founder and CEO of the Ark Invest exchange-traded funds (ETFs) has seen many of her key investments falter over the past year and change. Exact Sciences was a market darling for Wood in 2020, but it's been largely downhill since the stock peaked early last year.
Yahoo Finance Live anchors discuss Bed Bath & Beyond stock performance amid reports that the company has secured a loan deal.
Warren Buffett likes to talk about buying more S&P 500 stocks when they're cheaper. But it turns out he's human, too.
Notable business headlines include the FTC dropping Mark Zuckerberg from Meta’s antitrust suit, Amazon seller Pharmapacks to close after failing to secure financing to remain operating, and Tesla and Nio suspending EV charging amid China’s power crunch.
These companies have raised their payouts to shareholders throughout multiple recessions, military conflicts, and a global pandemic.
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Yahoo Finance anchors discuss trending tickers as Tesla's three-for-one stock split will go into effect after the closing bell and SoFi stock rises on anticipated student loan news.
This has been a challenging year in every sense of the word for Wall Street professionals and everyday investors. In 2022, this shining light is stock splits. Since the beginning of the year, dozens of companies have announced and/or enacted stock splits.
Not many hedge managers have ignited as much controversy as Cathie Wood. The founder of Ark Invest has built her brand on running against the crowd. From her early embrace of tech stocks to her outspoken political conservatism, Cathie Wood has always been something of a lightning rod. Whether her investments and stock strategies are panning out or not, one thing has always been consistent. Wood has never deviated from her path, and continues to this day to urge investors to stay the path. Wood h
Minerva's (NERV) stock surges after the company files an NDA-seeking FDA approval for its schizophrenia therapy.
Wedbush Securities Equity Research Analyst Alicia Reese joins Yahoo Finance Live to discuss AMC’s $APE share fluctuation, movie releases, box office expectations, amenities, bankruptcy, and financial growth.
The first time Tesla split its stock, back in August 2020, shares gained an incredible 81% between the split announcement and the day the stock split.
Tilray Brands, Inc. (TLRY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The board of Bank of America Corporation ( NYSE:BAC ) has announced that it will be paying its dividend of $0.22 on the…